Recent advancements in cancer vaccine development have demonstrated their potential for precise tumor targeting through ...

Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.

A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...

Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...

Major histocompatibility complex class II (MHC-II) molecules play a critical, yet historically overlooked, role in tumor immunity.

METiS TechBio ('METiS') today announced that two of its oncology pipeline candidates, MTS-105 and MTS-107, have been ...

A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.

Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive ...

One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...

Scientists at St. Jude Children's Research Hospital have characterized a hidden intermediate state at the center of Src ...